Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare
Bionano Genomics Inc. Operating Income 2017–2025
Bionano Genomics Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bionano Genomics Inc. operating income for the quarter ending March 31, 2026 was -7.9 M, a 6.71% decrease year-over-year.
- Bionano Genomics Inc. operating income for the twelve months ending March 31, 2026 was -32.7 M, a 84.07% decrease year-over-year.
- Bionano Genomics Inc. annual operating income for 2025 was -33.3 M, a 67.94% decrease from 2024.
- Bionano Genomics Inc. annual operating income for 2024 was -104.0 M, a 51.69% decrease from 2023.
- Bionano Genomics Inc. annual operating income for 2023 was -215.2 M, a 63.44% increase from 2022.
- Bionano Genomics Inc. annual operating income for 2022 was -131.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bionano Genomics Inc. Operating Income — FAQ
Bionano Genomics Inc. (BNGO) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Bionano Genomics Inc.'s operating income?
Bionano Genomics Inc. (BNGO) reported operating income of -$33M for fiscal 2025.
Where can I see BNGO's operating income history?
The chart and table above show Bionano Genomics Inc.'s operating income by year and by quarter, including the growth rate.